Abstracts tagged "Ankylosing spondylitis (AS) and microbiome"

Abstract Number: 2079 • 2018 ACR/ARHP Annual Meeting
Dysbiosis of Gut Microbiomes in Ankylosing Spondylitis
Chen Zhou¹, Xuan Zhang² and Xiao Xinyue¹, ¹Peking Union Medical College Hospital, Beijing, China, ²Rheumatology, Peking Union Medical College Hospital, Beijing, China
Background/Purpose: Ankylosing spondylitis (AS) is a common chronic, systemic, inflammatory disease. Gut microbiome has been reported to play an important role in the homeostasis of…
Abstract Number: 3166 • 2016 ACR/ARHP Annual Meeting
HLA-B27 and Ankylosing Spondylitis Have Shared Effects on the Gut Microbiome
Mary-Ellen Costello¹, Mark Asquith², Kim-Anh Lê Cao³, Tammy Martin⁴, Sarah Diamond², Michelle Beaumont⁵, Timothy D. Spector⁵, James T. Rosenbaum² and Matthew A. Brown¹, ¹Translational Research Institute, Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia, ²Oregon Health & Science University, Portland, OR, ³Translational Research Instiute, The University of Queensland Diamantina Institute, Brisbane, Australia, ⁴Ophthalmology, Oregon Health & Science Univ, Portland, OR, ⁵Dept of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom
Background/Purpose: Evidence for a discrete intestinal microbiome signature in the terminal ileum (TI) of ankylosing spondylitis (AS) patients, compared to healthy controls, has recently been…
Abstract Number: 2497 • 2013 ACR/ARHP Annual Meeting
Evidence Of a Microbial Signature In The Intestinal Microbiome In Ankylosing Spondylitis
Mary-Ellen Costello¹, Francesco Ciccia², Brooke Gardiner³, Mhairi Marshall³, Dana Willner⁴, Tony Kenna³, Giovanni Triolo² and Matthew A. Brown³, ¹Human Genetics Group, University of Queensland Diamantina Institute, Brisbane, Australia, ²Rheumatology Unit, University of Palermo, Palermo, Italy, ³University of Queensland Diamantina Institute, Brisbane, Australia, ⁴Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia
Background/Purpose: Ankylosing spondylitis (AS) occurs in genetically predisposed individuals exposed to an unknown but likely ubiquitous environmental trigger. In both AS and Crohn’s disease (CD)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].